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Antimicrobial resistance 
among pathogenic bacteria from mink 
(Neovison vison) in Denmark
Nanett Kvist Nikolaisen, Desireé Corvera Kløve Lassen, Mariann Chriél, Gitte Larsen, Vibeke Frøkjær Jensen 
and Karl Pedersen* 
Abstract 
Background: For proper treatment of bacterial infections in mink, knowledge of the causative agents and their 
antimicrobial susceptibility patterns is crucial. The used antimicrobials are in general not registered for mink, i.e. most 
usage is “off-label”. In this study, we report the patterns of antimicrobial resistance among pathogenic bacteria isolated 
from Danish mink during the period 2014–2016. The aim of this investigation was to provide data on antimicrobial 
resistance and consumption, to serve as background knowledge for new veterinary guidelines for prudent and opti-
mal antimicrobial usage in mink.
Results: A total number of 308 Escherichia coli isolates, 41 Pseudomonas aeruginosa, 36 Streptococcus canis, 30 Strepto-
coccus dysgalactiae, 55 Staphylococcus delphini, 9 Staphylococcus aureus, and 20 Staphylococcus schleiferi were included 
in this study. Among E. coli, resistance was observed more frequently among the hemolytic isolates than among the 
non-hemolytic ones. The highest frequency of resistance was found to ampicillin, 82.3% and 48.0% of the hemolytic 
of the non-hemolytic isolates, respectively. The majority of the P. aeruginosa isolates were only sensitive to ciprofloxa-
cin and gentamicin. Among the Staphylococcus spp., the highest occurrence of resistance was found for tetracycline. 
Regarding the nine S. aureus, one isolate was resistant to cefoxitin indicating it was a methicillin-resistant Staphylococ-
cus aureus. Both β-hemolytic Streptococcus species showed high levels of resistance to tetracycline and erythromy-
cin. The antimicrobial consumption increased significantly during 2007–2012, and fluctuated at a high level during 
2012–2016, except for a temporary drop in 2013–2014. The majority of the prescribed antimicrobials were aminopeni-
cillins followed by tetracyclines and macrolides.
Conclusions: The study showed that antimicrobial resistance was common in most pathogenic bacteria from mink, 
in particular hemolytic E. coli. There is a need of guidelines for prudent use of antimicrobials for mink.
Keywords: Antimicrobial consumption, Antimicrobial resistance, Escherichia coli, Mink, Neovison vison, Pseudomonas 
aeruginosa, Staphylococcus delphini, Streptococcus canis
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Background
The Danish production of mink (Neovison vison) skins 
was over 17 million annually (2013–2016). In 2016, this 
corresponded to 30% of the world production of 55.7 mil-
lion skins [1]. In the Danish mink production, a range of 
bacterial species are causing a wide variety of infectious 
diseases. Among the most important ones are Escheri-
chia coli (causing e.g. enteritis, pneumonia, and septice-
mia), Streptococcus canis and Streptococcus dysgalactiae 
(e.g. pneumonia, wound infections, and mastitis), various 
staphylococci such as Staphylococcus delphini, Staphylo-
coccus aureus, and Staphylococcus schleiferi (e.g. wound 
infections, dermatitis, pleuritis, pneumonia, and mas-
titis) and Pseudomonas aeruginosa (e.g. hemorrhagic 
pneumonia) [2]. Antimicrobials are prescribed for treat-
ment of these infections, but the usage of antimicrobial 
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drugs may lead to the selection for resistance [3, 4]. 
Therefore, it is important to follow the development of 
resistance over time for the major bacterial pathogens. 
The consumption of antimicrobials for mink in Denmark 
increased over several years up to 2012 [5, 6]. Rising 
public focus on animal welfare may have contributed to 
the increase in 2011–2012 [6]. On the other hand, rising 
focus on antimicrobial consumption in the mink produc-
tion may have contributed to the significant decrease in 
2013 and 2014 [5, 6].
At present, only one antimicrobial product containing 
oxytetracycline is registered specifically for use in mink 
on the Danish market. Therefore, most antimicrobial use 
is “off-label” and dosages are extrapolated from other ani-
mal species, for which the products are registered, while 
knowledge on absorption and plasma concentrations in 
mink are sparse.
Here we present the results of the surveillance of anti-
microbial resistance among pathogenic bacteria isolated 
from mink submitted for diagnostic at the National Vet-
erinary Laboratory in a 3-year period, 2014–2016, and 
compare the results with previous data. The reported 
findings of antimicrobial resistance levels are discussed 
in relation to patterns in antimicrobial prescription for 
mink.
Methods
Bacterial isolates and culture conditions
Bacterial isolates were obtained from clinical samples 
from carcasses submitted to the National Veterinary 
Institute, DTU, during the period 2014–2016. The iso-
lates were considered causative agents in infections that 
had led to the submission of the animals for laboratory 
examination. They had been recovered from pathological 
material by conventional culture methods and identified 
by matrix-associated laser desorption/ionization—time 
of flight mass spectrometry (MALDI-TOF MS). Mass 
spectra were obtained using an Autoflex Speed instru-
ment (Bruker Daltonics, Bremen, Germany) calibrated 
with the Bruker Escherichia coli Bacterial Test Standard 
for Mass Spectrometry. Isolates were analysed with the 
MALDI Biotyper RTC 3.1 software using a BDAL data-
base of library spectra (Bruker Daltonics). Only one iso-
late was included from each submission. They originated 
from many farms (n =  284 out of approx. 1400 Danish 
mink farms) and were assumed to be representative for 
Danish mink farms.
The E. coli isolates (n = 308) consisted of 158 hemolytic 
and 150 non-hemolytic isolates. They were derived from 
samples of liver, lung, mammary gland, feces, intestine, 
spleen, or uterus. The S. canis (n = 36) and S. dysgalac-
tiae (n = 30) isolates were derived from mammary gland, 
liver, lung, paw, skin, or thoracic cavity. The staphylococci 
included in this investigation were primarily of the spe-
cies S. delphini (n = 55) and a few of S. aureus (n = 9) or 
S. schleiferi (n = 20). They were derived from lung, liver, 
urine, skin, uterus, nose, or kidney. Isolates of P. aerugi-
nosa (n = 41) were mainly isolated from the lung, except 
a few deriving from the spleen, liver, or thoracic cavity; 
all P. aeruginosa isolates were found in association with 
outbreaks of hemorrhagic pneumonia.
Antimicrobial susceptibility testing
The minimal inhibitory concentration (MIC) of different 
antimicrobial agents was determined by the broth dilu-
tion susceptibility testing method using a semiautomatic 
system (SensiTitre, Trek Diagnostic Systems Ltd., UK) 
according to recommendations by the Clinical Labora-
tory Standards Institute [7]. The susceptibility test-panels 
and their test ranges are presented in Tables 1, 2, 3, 4, 5, 6 
and 7. In the test result for P. aeruginosa, only apramycin, 
ciprofloxacin, colistin, gentamicin, spectinomycin, and 
streptomycin were reported due to intrinsic resistance 
towards the remaining antimicrobials [8, 9] (Table 3).      
MIC values were interpreted using clinical breakpoints 
when available [see Additional file 1]. Since there are no 
approved breakpoints for mink pathogens, these inter-
pretations must be regarded cautiously. Test ranges were 
as stated by Pedersen et al. [10]. Resistance percentages 
were calculated from isolates with MIC values above the 
breakpoint for resistance. In this study, the resistance 
level for each antimicrobial was considered low when 
<10% of the isolates were above the resistance breakpoint 
and considered high when resistance levels were >40%. 
Comparison between resistance levels in hemolytic and 
non-hemolytic E. coli was performed by using a Fisher’s 
exact test [11]. Results were considered significant when 
P < 0.05.
Consumption of antimicrobial agents
Data on antimicrobial consumption in mink from 2007 
to 2016 were extracted from the national veterinary pre-
scription database, VetStat [12, 13]. VetStat data are con-
sidered to cover more than 99% of the total prescribed 
amounts of antimicrobials for veterinary use [14]. This 
study included all records on sales of antimicrobial drug 
for systemic use when (1) prescribed for mink, and/or 
(2) prescribed to mink farms with no other animal spe-
cies recorded on the farm. The temporal developments in 
antimicrobial consumption were presented as annual kg 
active compound together with the trend in number of 
breeding females as a measure of population size.
To enable comparison of individual classes of antimi-
crobials, the consumption was measured in Defined Ani-
mal Doses. To adjust for fluctuations in population size, 
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an estimated treatment proportion (TP) per year was cal-
culated as;
TP =
∑ active compound
DADDkg ∗
(
animal biomass ∗ days
)
where DADDkg (mg/kg) is the number of defined daily 
dosage for treatment of one kg biomass, defined on prod-
uct level as the recommended average daily dose, accord-
ing to the principles described previously by Jensen et al. 
Table 1 MIC distributions and occurrence of resistance of hemolytic Escherichia coli (n = 158) isolates from Danish mink 
(2014–2016)
Distribution (n) of MICs (µg/ml)
0.015 0.031 0.063 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 2048 %R
Amox + clav 12 23 110 11 2 1.3
Ampicillin 2 17 8 1 130 82.3
Apramycin 110 42 5 1 0.6
Cefotaxime 154 1 1 2 1.9
Ceftiofur 156 1 1 0.6
Chloramphenicol 4 96 50 3 2 3 5.1
Ciprofloxacin 106 50 1 1 0
Colistin 150 7 1 0.6
Florfenicol 8 122 24 4 2.5
Gentamicin 52 93 8 1 4 2.5
Nalidixic acid 155 1 2 1.9
Neomycin 128 25 2 3 3.2
Spectinomycin 113 12 7 6 9 11 16.5
Streptomycin 53 14 7 16 20 48 57.6
Sulphamethoxazole 69 89 56.3
Tetracycline 69 2 1 2 84 55.1
Trimethoprim 93 1 64 40.5
Vertical lines indicate breakpoints for resistance (see breakpoint table in Additional file 1 A). White fields indicate test range for each antimicrobial. Values greater than 
the test range represent MIC values greater than the highest concentration in the range. MICs equal to or lower than the lowest concentration, are given as the lowest 
concentration in the test range
R resistance, n number of isolates, amox + clav amoxicillin with clavulanic acid (1:2)
Table 2 MIC distributions and  occurrence of  resistance of  non-hemolytic Escherichia coli (n =  150) isolates from  Danish 
mink (2014–2016)
Distribution (n) of MICs (µg/ml)
0.015 0.031 0.063 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 2048 %R
Amox + clav 21 52 64 12 1 0.7
Ampicillin 2 29 42 5 72 48.0
Apramycin 103 43 4 0
Cefotaxime 146 3 1 0.7
Ceftiofur 147 2 1 0.7
Chloramphenicol 6 61 74 2 2 5 4.7
Ciprofloxacin 83 53 3 2 2 1 6 4.0
Colistin 144 6 0
Florfenicol 8 93 47 1 1 1.3
Gentamicin 52 88 9 1 0
Nalidixic acid 138 3 9 6.0
Neomycin 123 18 2 1 1 5 4.7
Spectinomycin 107 21 3 5 14 14.7
Streptomycin 86 12 5 2 11 34 34.7
Sulphamethoxazole 97 53 35.3
Tetracycline 98 10 42 28.0
Trimethoprim 114 36 24.0
Vertical lines indicate breakpoints for resistance (see breakpoint table in Additional file 1 A). White fields indicate test range for each antimicrobial. Values greater than 
the test range represent MIC values greater than the highest concentration in the range. MICs equal to or lower than the lowest concentration, are given as the lowest 
concentration in the test range
R resistance, n number of isolates, amox + clav amoxicillin with clavulanic acid (1:2)
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[5]; active compound was the annual antimicrobial use 
summarized on 4th or 5th ATCvet level [15]; the live 
animal biomass was estimated from number of breeding 
females registered at Kopenhagen Fur, and data on litter 
size and growth, as described by Jensen et al. [5]. A TP of 
10 DADD/1000 biomass × days corresponds to 1% of the 
population biomass being treated on an average day.
Results
Resistance occurrence
In the hemolytic E. coli isolates, the highest occurrence of 
resistance was recorded for ampicillin (82.3%). Addition-
ally, high resistance levels were found for streptomycin, 
sulphonamides, tetracyclines, and trimethoprim (>40%) 
(Table 1). For these compounds as well as spectinomycin, 
resistant isolates were recorded from any sampling site. 
For other tested antimicrobials, resistance levels were 
low.
Among the hemolytic E. coli, 45 different phenotypic 
resistance profiles were recorded. Only 19 of 158 isolates 
were sensitive to all 17 tested antimicrobials. Multire-
sistance, i.e. being resistant to three or more compounds, 
was recorded in 60% of all the isolates. The most com-
mon phenotypes were resistant to ampicillin-strepto-
mycin-sulphonamide-tetracycline/trimethoprim (see 
Additional file 2). Mono-resistance was recorded in 10% 
of the isolates. Resistance for up to 10 compounds was 
recorded.
Table 3 MIC distributions and occurrence of resistance of  Pseudomonas aeruginosa (n = 41) isolates from Danish mink 
(2014–2016)
Distribution (n) of MICs (µg/ml)
0.015 0.031 0.063 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 2048 %R
Apramycin 31 10 -
Ciprofloxacin 1 21 13 5 1 0
Colistin 14 20 6 1 17
Gentamicin 4 26 11 0
Spectinomycin 1 5 16 19 -
Streptomycin 2 6 26 7 -
Vertical lines indicate breakpoints for resistance when available (see breakpoint table in Additional file 1 A). White fields indicate test range for each antimicrobial. 
Values greater than the test range represent MIC values greater than the highest concentration in the range. MICs equal to or lower than the lowest concentration, are 
given as the lowest concentration in the test range
R resistance, n number of isolates
Table 4 MIC distributions and occurrence of resistance of Streptococcus canis (n = 36) isolates from Danish mink (2014–
2016)
Distribution (n) of MICs (µg/ml)
0.063 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 %R
Cefoxitin 24 11 1 -
Chloramphenicol 15 21 0
Ciprofloxacin 16 20 0
Erythromycin 17 1 18 53
Forfenicol 15 21 0
Gentamicin 1 1 14 19 1 -
Penicillin 34 2 6
Spectinomycin 21 3 1 11 -
Streptomycin 3 14 2 1 16 -
Sulphamethoxazole 9 13 3 11 -
Tetracycline 1 1 34 97
Tiamulin 21 2 1 2 10 -
TMP+Sulpha 36 0
Trimethoprim 29 4 3 0
Vertical lines indicate breakpoints for resistance when available (see breakpoint table in Additional file 1 B). White fields indicate test range for each antimicrobial. 
Values greater than the test range represent MIC values greater than the highest concentration in the range. MICs equal to or lower than the lowest concentration, are 
given as the lowest concentration in the test range
R resistance, n number of isolates, TMP + Sulpha trimethoprim with sulphamethoxazole (1:19)
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Resistance among the non-hemolytic E. coli isolates was 
also highest for ampicillin (48%), followed by streptomy-
cin, sulphonamide, and trimethoprim (>25%) (Table  2). 
For these antimicrobials and tetracycline, resistant iso-
lates were observed for all kind of samples. For other 
tested antimicrobials, resistance was at low levels.
The hemolytic and non-hemolytic E. coli isolates 
showed similar resistance patterns, e.g. both showed the 
highest level of resistance to ampicillin. However, higher 
levels of resistance were in general observed among 
the hemolytic isolates than among the non-hemolytic 
isolates (Tables  1, 2). The differences were statistically 
Table 5 MIC distributions and occurrence of resistance of Streptococcus dysgalactiae (n = 30) isolates from Danish mink 
(2014–2016)
Distribution (n) of MICs (µg/ml)
0.063 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 %R
Cefoxitin 1 24 5 -
Chloramphenicol 5 24 1 0
Ciprofloxacin 1 19 10 0
Erythromycin 12 1 17 57
Forfenicol 5 24 1 0
Gentamicin 3 15 11 1 -
Penicillin 30 0
Spectinomycin 16 4 10 -
Streptomycin 1 4 7 1 1 16 -
Sulphamethoxazole 17 4 3 2 1 3 -
Tetracycline 1 1 1 2 6 19 83
Tiamulin 15 1 14 -
TMP+Sulpha 30 0
Trimethoprim 18 11 1 0
Vertical lines indicate breakpoints for resistance when available (see breakpoint table in Additional file 1 B). White fields indicate test range for each antimicrobial. 
Values greater than the test range represent MIC values greater than the highest concentration in the range. MICs equal to or lower than the lowest concentration, are 
given as the lowest concentration in the test range
Table 6 MIC distributions and  occurrence of  resistance of  Staphylococcus delphini (n =  55) isolates from  Danish mink 
(2014–2016)
Distribution (n) of MICs (µg/ml)
0.063 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 %R
Cefoxitin 33 20 1 1 0
Chloramphenicol 1 24 29 1 0
Ciprofloxacin 30 22 2 1 0
Erythromycin 17 25 1 1 11 20
Forfenicol 2 32 21 0
Gentamicin 54 1 0
Penicillin 18 11 15 2 3 3 2 1 47
Spectinomycin 21 30 4 7
Streptomycin 45 7 1 2 5
Sulphamethoxazole 47 5 3 0
Tetracycline 25 2 3 25 51
Tiamulin 53 1 1 0
TMP+Sulpha 54 1 2
Trimethoprim 2 10 24 17 1 1 2
Vertical lines indicate breakpoints for resistance (see breakpoint table in Additional file 1 B). White fields indicate test range for each antimicrobial. Values greater than 
the test range represent MIC values greater than the highest concentration in the range. MICs equal to or lower than the lowest concentration, are given as the lowest 
concentration in the test range
R resistance, n number of isolates, TMP + Sulpha trimethoprim with sulphamethoxazole (1:19)
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significant for ciprofloxacin (P  <  0.03) and highly sig-
nificant (P  <  0.001) for ampicillin, streptomycin, sul-
phonamide, tetracycline and trimethoprim. Only for 
ciprofloxacin the resistance levels were higher in the non-
hemolytic isolates (4%) than in the hemolytic isolates 
(1%) (Tables 1, 2).
All the 41 P. aeruginosa isolates were sensitive to cip-
rofloxacin and gentamicin. Colistin resistance was found 
in 17% of the isolates. All isolates were susceptible to 
apramycin in a concentration below 16 µg/mL (Table 3).
The two species of beta-hemolytic streptococci tested 
in this study, presented similar resistance patterns 
(Tables 4, 5). The majority of the 36 S. canis isolates and 
the 30 S. dysgalactiae isolates were resistant to tetracy-
cline (97% and 83%, respectively). Additionally, high 
levels of resistance to erythromycin were found in both 
streptococci species with more than 40% of the isolates 
(Tables  4, 5). As all the isolates of S. dysgalactiae were 
sensitive to penicillin, and two of the S. canis isolates 
were resistant.
The two staphylococcus species tested in this study, 
presented similar resistance patterns except for penicillin 
(Tables 6, 7). Among the 55 S. delphini isolates the high-
est occurrence of resistance were found for tetracycline 
(51%), penicillin (47%) and erythromycin (20%) (Table 6). 
Among the 20 S. schleiferi isolates about half of the iso-
lates were resistant to tetracyclines, but only two isolates 
were resistant penicillin (Table 7).
Only nine S. aureus isolates were available for test-
ing. They were susceptible to the majority of the tested 
antimicrobials, while five of the isolates were resistant to 
penicillin and four to tetracyclines. One of the isolates 
was resistant to cefoxitin, suggesting that this S. aureus 
isolate was a methicillin-resistant S. aureus (MRSA).
Antimicrobial consumption
The overall antimicrobial consumption in the mink pro-
duction measured in kg active compound, increased by 
130% from 2007 to 2012, followed by a slight tempo-
rary decrease, most pronounced in 2014 (Fig.  1). From 
2010 there has been an increase in number of breeding 
females, which may explain for some of the increase in 
usage (Fig. 1). Taking into account the changes in popu-
lation size, the antimicrobial consumption increased by 
109%, from 23 DADD/(1000 biomass  ×  days) in 2007 
to 48 DADD/(1000 biomass  ×  days) in 2012 (Fig.  2). 
In 2014, the antimicrobial consumption decreased to 
around 30 DADD/(1000 biomass  ×  days), and since 
increasing towards 40 DADD/(1000 biomass ×  days) in 
2016. The rise during the period 2007–2012 was mainly 
related to the use of aminopenicillins (mainly amoxicil-
lin), tetracyclines and macrolides, which are by far the 
most frequently used antimicrobials in the mink pro-
duction (Fig.  2). Lincomycin in combination with spec-
tinomycin has been commonly used, but it has been 
decreasing the past years. Cephalosporins and fluoro-
quinolones comprised less than 0.01% of the antimicro-
bial consumption in Danish mink during 2007–2012; 
amphenicols (florfenicol) comprised 0.06% and colistin 
comprised 0.2% of the consumption.
Table 7 MIC distributions and  occurrence of  resistance of  Staphylococcus schleiferi (n =  20) isolates from  Danish mink 
(2014–2016)
Distribution (n) of MICs (µg/ml)
0.063 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 %R
Cefoxitin 17 2 1 0
Chloramphenicol 17 3 0
Ciprofloxacin 8 12 0
Erythromycin 19 1 5
Forfenicol 18 2 0
Gentamicin 17 3 0
Penicillin 18 1 1 10
Spectinomycin 13 6 1 5
Streptomycin 13 7 0
Sulphamethoxazole 11 8 1 0
Tetracycline 9 1 10 55
Tiamulin 14 5 1 0
TMP+Sulpha 19 1 0
Trimethoprim 2 16 2 0
Vertical lines indicate breakpoints for resistance (see breakpoint table in Additional file 1 B). White fields indicate test range for each antimicrobial. Values greater than 
the test range represent MIC values greater than the highest concentration in the range. MICs equal to or lower than the lowest concentration, are given as the lowest 
concentration in the test range
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The seasonal pattern shows a dramatic peak in anti-
microbial consumption in May (Fig.  3a). This is true 
for all antimicrobial classes, but most pronounced 
for the most used antimicrobials; aminopenicillins, 
macrolides, lincosamides with spectinomycin, and 
tetracyclines (Fig.  3a). The prescription of tetracycline 
also increases into the autumn (June–October), when 
the kits are growing and the biomass is significantly 
higher (Fig.  3b). In contrast, during the period from 
pelting (November–December) until the whelping 
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season (May), the prescription of antimicrobial was 
very low (Fig. 3b).
Discussion
In the present study, by far the highest level of resistance 
in E. coli was recorded for ampicillin, with 82.3% of the 
hemolytic and 48.0% of the non-hemolytic isolates. A 
similar observation was reflected in a previous study on 
antimicrobial susceptibility in mink pathogens, where the 
highest occurrence of resistance was found to ampicillin 
[2]. The same study showed that streptomycin, tetracy-
clines, sulphonamides, spectinomycin, and trimethoprim 
were associated with the highest levels of resistance [2]. 
These antimicrobial classes together with the aminopeni-
cillins are also the most commonly used, but much fewer 
animals are treated with these drugs compared to amin-
openicillins (Fig. 3b).
The resistance profiles of E. coli, with more than 50% 
of the isolates being resistant to sulphonamide and strep-
tomycin, which are not commonly used in Danish mink, 
might be related to usage and/or to co-selection [16]. The 
potential of E. coli to transfer resistance plasmids and 
thereby spread antimicrobial resistance is well known; 
several resistance genes have been discovered, some 
genes give multiple resistances, and numerous resistance 
genes can be found within one isolate [17]. In this study, 
a high level of resistance to streptomycin was recorded, 
and as streptomycin is not used in mink, co-selection is 
the most likely cause [16, 17].
For both the hemolytic (1.9%) and non-hemolytic 
(0.7%) E. coli, a low number of cefotaxime resistant iso-
lates were found. This resistance might indicate extended 
spectrum beta-lactamases (ESBL) status, but it was not 
investigated further in this study.
When comparing the hemolytic and non-hemolytic E. 
coli, resistance for most compounds was higher among 
the hemolytic isolates than among the non-hemolytic 
ones. A similar observation was made in a previous study, 
comparing hemolytic and non-hemolytic E. coli in Dan-
ish mink [18]. The reason for this is not known, and there 
is currently no evidence to suggest that these strains 
are more virulent to mink or more likely to be exposed 
to antimicrobials and subsequently develop resistance. 
However, this needs to be further investigated. In pigs, 
the hemolytic E. coli O149 is the most important patho-
gen in weaning diarrhea, and hemolysis is thought to be 
involved in the pathogenesis, although other toxins than 
hemolysin are known to be important [19].
In mink, P. aeruginosa is causative of hemorrhagic 
pneumonia, and this bacterium is well recognized 
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microbial class in the Danish mink production (2007–2016). a The 
graph is a monthly average from the time period 2007–2016, and 
illustrates the seasonal pattern in antimicrobial consumption. DADD 
defined animal daily dose is the assumed average maintenance dose 
needed to treat one kg animal. b The graph is a monthly average 
from the time period 2007–2016, and illustrates the seasonal pattern 
in antimicrobial consumption relative to the size of Danish mink 
production (monthly average, 2007–2016). DADD/(1000 kg – bio-
mass * day) = number of DADD’s used within a given period per 
tonnes live biomass multiplied by number of days at risk within the 
time period (month), the unit describes the prescribed antimicrobials 
relative to the biomass on the farm, i.e. the decrease during autumn 
as the kits grow and the biomass increases. Others: Pleuromutilins, 
amphenicols, aminoglycosides, cephalosporins, colistin, fluoroqui-
nolones, penicillin. TMP + sulpha: trimethoprim with sulphonamide
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because of its intrinsic resistance to most antimicrobi-
als [8, 9]. High susceptibility was found to ciprofloxa-
cin, colistin, and gentamicin. The few colistin-resistant 
strains found in this study might belong to the Gaussian 
distribution of the susceptible wild types (Table 3). In a 
previous study, all P. aeruginosa isolates were found sus-
ceptible to gentamicin and colistin [2].
In this study, both group G (S. canis) and group C (S. 
dysgalactiae) streptococci were investigated. In the two 
streptococcus species, high resistance levels to tetracy-
cline were found; S. canis: 97% and S. dysgalactiae: 83%. 
High levels of resistance to tetracycline were also found 
in a previous study [2]. Resistance to macrolides, repre-
sented by erythromycin was high in data from 2008 [2] 
and this pattern was also found in the present study with 
more than 50% of the isolates being resistant in both 
species (Tables  4, 5). Whether the high levels of resist-
ance to macrolides and tetracycline reflects the similarly 
high consumption of these compounds (Fig. 2) is uncer-
tain. The tiamulin and spectinomycin MIC distributions 
showed a distinct division into two groups in both spe-
cies. This might indicate the grouping of susceptible wild 
type and a resistant population (Tables  4, 5). Penicillin 
resistance was low in the streptococci despite high con-
sumption of aminopenicillins; this is a pattern known also 
from other species, e.g. humans and cattle [20]. In this 
study, two S. canis isolates had a MIC value of 0.25 µg/
mL to penicillin while the other isolates had MIC values 
≤0.063 µg/mL. This needs to be further investigated.
The taxonomy of staphylococci has changed so that 
isolates from mink that were previously identified as S. 
intermedius are now considered to belong to the species 
S. delphini. Thus, the isolates reported by Pedersen et al. 
[2] as S. intermedius were likely all S. delphini. Among 
S. delphini, far the highest level of resistance was found 
to tetracycline (51%). A similar pattern was observed in 
2008 [2], as high levels of resistant isolates were found to 
tetracycline, penicillin and erythromycin.
One of the S. aureus isolates was resistant to cefoxitin. 
This observation subsequently prompted an investiga-
tion of occurrence of MRSA in mink, and it has become 
evident that MRSA is widespread on Danish mink farms. 
The majority of the isolates are livestock-associated 
MRSA CC398, and belonging to spa-types t034 and t011, 
which are also most prevalent in pigs [21].
In general, the occurrence of resistance towards cepha-
losporins and fluoroquinolones is very low in bacterial 
isolates from Danish mink, most likely due to the very 
low consumption of the compounds both in Danish mink 
and other production animals in Denmark (Fig. 2) [20].
There was a marked increase in antimicrobial pre-
scription in May (Fig.  3a). The reason is probably that 
that mink kits are born around early May, and the 
antimicrobials are mainly for treatment of pre–weaning 
mink diarrhea. In the peri-weaning period May–July, the 
prescription of aminopenicillins was 27% higher than 
macrolides and 75% higher compared to the use of tet-
racyclines. In contrast, tetracyclines were used 10% more 
than aminopenicillins and 65% more than macrolides 
in autumn. Thus aminopenicillins are in general used 
to treat pre- and post-weaning animals in the spring, 
whereas tetracyclines are used mainly in the almost 
full-grown animals in the autumn. Consequently, more 
animals can be treated with the given amount of amin-
openicillins in the spring, than the tetracycline in the 
autumn. This explains the difference between Fig. 3a, b.
Conclusions
For E. coli, high levels of resistance were recorded, espe-
cially among hemolytic isolates, to the most used com-
pounds ampicillin and tetracyclines. High resistance 
levels to streptomycin and sulphonamides were recorded, 
probably due to co-resistance. The most commonly used 
antimicrobials are also reflected in the resistance patterns 
of Gram positive bacteria. The antimicrobial consump-
tion data displays an overall decrease from 2011 to 2014, 
and then a gradual increase in 2015 and 2016.
There is a need for guidelines regarding treatment and 
susceptibility of relevant pathogens in Danish mink for 
veterinarians and farmers to optimize (and minimize) the 
use of antimicrobial compounds.
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